Roche’s Alecensa has won NICE backing as a treatment for a rare type of lung cancer, over-turning a prior decision to reject NHS funding for the drug. More: NICE backs Roche’s Alecensa Source: News
read moreAcelRx’ Dzuveo has won approval in the European Unionl for the management of acute moderate to severe pain in medically monitored settings. More: EU approval for AcelRx' Dzuveo Source: News
read moreThe US Food and Drug Administration will undertake a priority review of Genentech’s experimental flu drug baloxavir marboxil in people aged 12 years and older. More: Priority review for Genentech’s flu drug Source: News
read moreShares in Oxford University spin out Summit Therapeutics have taken a nosedive after the firm’s flagship drug ezutromid failed to hit targets in a mid-stage trial in patients with Duchenne muscular dystrophy (DMD). More: Summit shares plummet on DMD drug
read moreArray will challenge pharma giants Novartis and Roche in its rollout of new cancer drugs Braftovi and Mektovi. More: Ready to challenge Novartis and Roche, Array scores FDA nod for melanoma combo Source: fierce
read moreWomen only hold a quarter of all C-level biopharma jobs, and when they do make it to the top, women are overall paid far less compared to many of their male counterparts. Here, we list the top 5 highest-paid female
read more© 1994 - 2026 B.M. Pharmaceuticals